Why the total price hides the real comparison
Two hospitals can quote for what sounds like the same lymphoma treatment and still describe different work. One quote may assume the diagnosis is already confirmed and the next phase is decided. Another may include pathology re-review, staging scans, a multidisciplinary discussion or an initial monitoring period. The totals are not comparable because the clinical starting point is not the same.
Lymphoma is not one disease. The National Cancer Institute notes that lymphoma includes Hodgkin and non-Hodgkin types, and the exact diagnosis matters when treatment is discussed. A quote built on an unconfirmed subtype, or on a different subtype assumption, cannot be lined up against another quote as if both were the same service.
The practical rule is to compare scope first and price second. Ask each hospital to state, in writing, the diagnosis it is pricing, the treatment phase it is pricing, and the records it has actually reviewed. Without those three answers, a lower total may simply mean less has been included.
The records that make two quotes comparable
For a lymphoma second-step review, the records that most affect whether quotes can be compared are the pathology report and the treatment history. The pathology report identifies the subtype and any markers the treating team used to classify it. The treatment history shows which regimens were given, in what order, and how the disease responded.
Response records matter because they change what the next step is. Imaging reports, scan dates, laboratory trends and clinic notes describing response or progression all feed into whether a hospital is pricing consolidation, a change of approach, monitoring or something else. If one hospital has these records and another does not, their quotes describe different clinical situations.
A useful way to prepare is to assemble a single indexed file: pathology report, any molecular or marker results, imaging reports with dates, treatment summaries listing regimens and cycles, and the most recent clinical note. Send the same file to each hospital you ask. That does not guarantee identical quotes, but it removes one common reason they differ.
Ask each hospital which of these documents it still needs before it can confirm scope. A quote issued before key records arrive is usually provisional, and the final figure may move once the file is complete.
Reading an itemised quote line by line
An itemised quote is only useful if the categories are specific. Look for separate lines for pathology or molecular review, imaging and staging, specialist consultations, the treatment itself, supportive medicines, bed or ward type, and monitoring during and after treatment. If a quote is a single figure with no breakdown, ask for the breakdown before comparing it with another.
Check whether each line is a confirmed charge, an estimate, or a range. Hospitals may price some items firmly and others provisionally, depending on what is still unknown. Ask which lines are fixed for the planned phase and which could change if the clinical picture shifts.
Check the time window. A quote may cover one admission, one cycle, one phase or a defined period. Two quotes covering different windows cannot be compared on total alone. Ask each hospital to state the period its figure covers and what happens at the end of that period.
Finally, ask what is explicitly outside the quote. Travel, accommodation, interpretation, companion services and some medicines may sit outside the hospital's figure. That does not make the quote wrong, but it changes what you are actually comparing.
Questions that expose a scope mismatch
The fastest way to find a mismatch is to ask both hospitals the same short set of questions and compare the answers side by side. Ask which lymphoma subtype the quote assumes, which prior regimens were reviewed, and what response evidence was used. Ask what the planned phase is and how many admissions or visits the figure covers.
Ask whether pathology re-review is included, whether staging or response imaging is included, and whether a multidisciplinary discussion is part of the plan. Ask what monitoring is included after treatment and who is responsible for it. Ask what would change the estimate and how you would be told.
If one hospital answers these questions and another does not, that difference is itself useful information. A hospital that can describe its scope clearly is easier to compare, even before you look at the total.
- Which subtype and records does this quote assume?
- Which treatment phase and time window does it cover?
- Which items are confirmed and which are estimates?
- What is excluded, and what would change the figure?
Where ChinaSpecialistCare fits, and where it does not
ChinaSpecialistCare provides information and non-clinical coordination. We can help you organise records, request specialist appointment coordination, and arrange interpretation or a companion during hospital visits. We do not diagnose, prescribe, decide suitability or promise hospital acceptance. Those decisions belong to the treating hospital and its licensed clinicians.
If you want a records-based opinion before travelling, a proxy consultation is available but optional. It is not a prerequisite for an appointment, and an initial enquiry does not require buying one. Hospital consultation fees, tests, treatment, medicines and rooms are paid to the hospital or relevant provider; our coordination fees are separate.
For lymphoma specifically, the relevant starting point is the lymphoma treatment page, which explains the treatment context. Use it alongside this guide when you prepare your records and questions.
One more distinction is worth keeping in view: a quote is a planning document, not a clinical decision. A hospital can price a phase only after its own clinicians have reviewed the records and agreed what that phase is. If two hospitals describe different next steps, the totals will differ for clinical reasons, not because one is cheaper.
That is why the same file matters. When both hospitals work from the same pathology report, the same treatment history and the same response evidence, any remaining difference in the quote usually points to a real difference in scope, ward type, monitoring plan or time window. Those are the differences you can actually discuss.
If a hospital cannot yet confirm scope because a record is missing, the useful response is to ask which document is missing and what it would change. That keeps the comparison moving without treating a provisional figure as final.
A short written summary of your own questions also helps. Note the subtype you understand you have, the regimens already given, the date of the most recent response assessment, and the specific decision you want the hospital to address. Sending that summary with the indexed file reduces the chance that each hospital answers a slightly different question.
None of this replaces the treating team's judgement about suitability, alternatives or timing. It simply makes the quotes you receive describe the same thing, which is the only basis on which a total is worth comparing.
A practical next step
Start with a short summary: the suspected or confirmed subtype, the main question you want answered, and the records you already hold. You do not need to send a complete medical archive or payment details at first contact. After the initial reply, you can share the indexed file described above with the hospitals or coordination route you choose.
Then ask each hospital for a written itemised quote tied to the same records and the same treatment phase. Compare scope, time window, inclusions and exclusions before you compare totals. If a figure looks lower, check what it leaves out. If a figure looks higher, check what it adds. The goal is not the cheapest number but the clearest description of what is being priced.
An initial enquiry is free. It is a way to clarify the next step, not a commitment to treatment or travel.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.